The ResApp share price is launching upwards after Pfizer upped its takeover bid for the company.
The post ResApp share price explodes 50% on new Pfizer deal appeared first on The Motley Fool Australia. –
The biopharmaceutical giant has agreed to acquire the Brisbane-based health technology company for 20.8 cents per share. Thatâs up from its previous bid of 14.6 cents.
The ResApp share price is trading at 18 cents right now, 50% higher than its previous close.
However, thatâs lower than its intraday high â and new 52-week high â of 19 cents.
Letâs take a closer look at the latest news from the takeover target.
ResApp share price takes off on upped takeover offer
The ResApp share price is soaring 50% on Wednesday after the company announced Pfizer has upped its takeover bid to 20.8 cents per share.
That sits within its assessed value range of 14.6 cents to 27.9 cents per ResApp share, as determined by an independent expert. It also values the company at around $179 million.
The pair have entered an amended scheme of arrangement agreement entailing the increased bid.
ResApp recommends shareholders vote in favour of the proposition in the absence of a superior proposal and subject to the independent expert continuing to conclude that the scheme is in investorsâ best interests.
How did we get here?
ResApp is the developer of a smartphone app designed to detect COVID-19 using cough sounds.
The tech was recently dealt a blow when a data confirmation study returned significantly worse results than a previous pilot study.
Pfizer first put a takeover proposal to ResApp in April. Then, it offered just 11.5 cents per share.
That bid was upped to either 20.7 cents or 14.6 cents in June. Though, the higher of the bids was dependent on positive findings from the data confirmation study, which hadnât been completed at the time.
Perhaps unsurprisingly, the ResApp share price plummeted 28.6% when the studyâs disappointing results were released.
The post ResApp share price explodes 50% on new Pfizer deal appeared first on The Motley Fool Australia.
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of July 7 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
‘Massive untapped demand’: The $3 trillion opportunity ASX 200 energy shares could be missing
Why is the Sezzle share price surging 8% on Wednesday?
Up 10%, what’s going on with the Zip share price today?
Up 10% in a month, is the CBA share price now fully valued?
Up 22% in a month, can the Imugene share price extend its rally?
Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.